Renaissancere Holdings Ltd. Buys Shares of 263,000 Trupanion, Inc. $TRUP

Renaissancere Holdings Ltd. bought a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 263,000 shares of the financial services provider’s stock, valued at approximately $6,514,510. Trupanion makes up approximately 0.0% of Renaissancere Holdings Ltd.’s holdings, making the stock its 5th biggest holding. Renaissancere Holdings Ltd. owned approximately 0.60% of Trupanion at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in TRUP. Kelleher Financial Advisors bought a new stake in Trupanion during the 2nd quarter worth approximately $42,000. Parallel Advisors LLC increased its stake in shares of Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares in the last quarter. Kemnay Advisory Services Inc. bought a new position in Trupanion in the fourth quarter valued at about $64,000. Advisory Services Network LLC purchased a new stake in Trupanion in the 3rd quarter worth $160,000. Finally, Fifth Third Bancorp lifted its position in shares of Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock worth $194,000 after purchasing an additional 7,336 shares during the last quarter.

Analyst Ratings Changes

Several research firms have recently commented on TRUP. Weiss Ratings upgraded Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday. Stifel Nicolaus raised their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday, August 20th. Finally, Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $45.00 to $32.00 in a research report on Wednesday. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $39.20.

Trupanion Trading Up 1.6%

Shares of NASDAQ TRUP traded up $0.48 during trading hours on Friday, hitting $30.13. 150,652 shares of the company traded hands, compared to its average volume of 438,236. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of 56.85, a price-to-earnings-growth ratio of 2.04 and a beta of 1.39. The company’s 50 day moving average price is $26.88 and its 200 day moving average price is $25.97. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $46.98.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.22 earnings per share. On average, equities research analysts anticipate that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Insider Transactions at Trupanion

In other Trupanion news, EVP Steve Weinrauch sold 6,674 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the transaction, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This trade represents a 7.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Margaret Tooth sold 978 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the transaction, the chief executive officer owned 175,401 shares in the company, valued at approximately $5,095,399.05. The trade was a 0.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 15,116 shares of company stock valued at $395,999 in the last three months. 5.58% of the stock is currently owned by corporate insiders.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.